Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “LABELLING”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 613 records · Page 34

Basic and Combination Cross-Features in X- and Q-band HYSCORE of the 15N Labeled Bacteriochlorophyll a Cation Radical

Abstract Chlorophylls are an essential class of cofactors found in all photosynthetic organisms. Upon absorbing a photon, the excited state energy of the chlorophyll can either be transferred to another acceptor molecule, or be used to drive electron transfer. When acting as the primary donor in the bacterial photosynthetic reaction center, light-induced charge separation results in the formation of a cationic bacteriochlorophyll dimer. The hyperfine interactions between the unpaired electron of the

Chemistry↗

SUMO Nitrogen Labeling Experiment and Soil Biogeochemistry

The Los Alamos Survival–Mortality experiment (SUMO) is located on Frijoles Mesa near Los Alamos, New Mexico, USA, at an elevation of 2150 m. This was a tree manipulation study that investigated the relative impacts of drought and warming on plant function and reveals how trees adapt to drought and heat in semi-arid regions. The study factored the role of tree hydraulic acclimation to both precipitation and temperature and separated their effects.The experiment is located in a pinon-juniper woodland near the ponderosa pine (Pinus ponderosa) forest ecotone. In a semi-arid woodland, adult trees (piñon and juniper) were exposed to chronic warming (+4 °C) and precipitation reduction (-45 %). After five years of continuous treatment exposure, soil and plant nitrogen isotopic composition were measured to assess plant nitrogen allocation. See SUMO Target Tree Information data package (doi:10.15485/1440544) for additional information. Data released by Los Alamos National Lab for public use under LA-UR-18-23656.

15N isotopic composition↗

International Review of Frameworks for Impact Evaluation of Appliance Standards, Labeling, and Incentives

In recent years, the number of energy efficiency policies implemented has grown very rapidly as energy security and climate change have become top policy issues for many governments around the world. Within the sphere of energy efficiency policy, governments (federal and local), electric utilities, and other types of businesses and institutions are implementing a wide variety of programs to spread energy efficiency practices in industry, buildings, transport, and electricity. As programs proliferate, there is an administrative and business imperative to evaluate the savings and processes of these programs to ensure that program funds spent are indeed leading to a more energy-efficient economy.

29 ENERGY PLANNING, POLICY, AND ECONOMY↗

Liquid Scintillation Counting - Packard Triple-Label Calibration

The Radiological Measurements Laboratory (RML) maintains and operates nine Packard Liquid Scintillation Counters (LSCs). These counters were obtained through various sources and were generally purchased as 2500, 2700 or 3100 series counters. In 2004/2005 the software and firmware on the counters were upgraded. The counters are now designated as 3100 series counters running the Quantasmart software package. Thus, a single procedure can be used to calibrate and operate the Packard LSCs.

61 RADIATION PROTECTION AND DOSIMETRY↗

Development of Cu-64 labeled EGF for In Vivo PET Imaging of EGFR Expression

In this project we proposed to establish feasibility of the development of targeted tracers for radionuclide imaging of epidermal growth factor receptors (EGFR) in cancer patients. The significance and impact of the proposed radiotracers are determined by the crucial role that EGFR plays in many cancers and by the rapid entrance of EGFR-inhibiting drugs into clinic. Clinical experience, however, revealed that only 10-25% of patients that are defined as EGFR-positive by immunohistochemical analysis respond to EGFR-directed therapeutics and there is poor correlation between EGFR immunohistochemistry and treatment. Therefore, for more efficacious use of EGFR-targeting therapeutics, there is a need for information about EGFR activity in patients. We hypothesized that radionuclide imaging of functionally active EGFR will provide such information and would allow for 1) rational patient stratification, 2) rapid monitoring of responses to therapy, and 3) development of personalized treatment regimens. We hypothesized that tracers based epidermal growth factor (EGF), a natural EGFR ligand, as a targeting vector would be particularly advantageous. First, only functionally active and therefore critical for disease progression EGFRs will bind and internalize an EGF-based tracer. Second, continuous internalization of EGF-based tracers by recyclable EGFR would lead to intracellular accumulation of radionuclide and improved signal-to-background ratio. Third, small size of EGF relative to antibodies would facilitate tumor penetration with vastly better non-specific soft tissue and blood clearance rates. Fourth, as a human protein, EGF is not expected to be immunogenic. Finally, at the beginning of this project, we have already engineered and expressed functionally active EGF with an N-terminal Cys-tag for site-specific conjugation of various payloads, including radionuclide chelators. In the Phase I of this project, in collaboration with Dr. Blankenberg’s group at Stanford University, 1. To synthesize and validate in vitro EGF-PEG-DOTA conjugate. The key accomplishment in this part of the project is synthesis of functionally active EGF-PEG-DOTA, construction, expression, and purification of functionally active Cys-tagged dimeric EGF (dEGF) and synthesis of corresponding dEGF-PEG-DOTA, development of protocols for radiolabeling EGF-PEG-DOTA and dEGF-PEG-DOTA with 64Cu. 2. To establish clearance, biodistribution, and stability of EGF-based PET 64Cu radiotracer. These characteristics are established for both EGF-PEG-DOTA/64Cu and dEGF-PEG-DOTA/64Cu and found to be comparable with reported data on 64Cu-radiolabeled antibodies. 3. To evaluate PET tumor imaging with EGF-based 64Cu radiotracer in mouse tumor models. Tumor imaging was evaluated in orthotopic human MDA231luc breast carcinoma model in SCID mice. Tracers accumulated in tumor area, allowing for detection of as small as few millimeter tumors. The Technical Objectives of the projects are accomplished and the results are published in Bioconjugate Chem. 20, 742, 2009.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

64 Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques

We present that the rupture of vulnerable atherosclerotic plaques that lead to stroke and myocardial infarction may be induced by macrophage infiltration and augmented by the expression of integrin α v β 3 . Indeed, atherosclerotic angiogenesis may be a promising marker of inflammation. In this study, an engineered integrin α v β 3 –targeting PET probe, 64 Cu-NOTA-3-4A, derived from a divalent knottin miniprotein was evaluated in a mouse model for carotid atherosclerotic plaques. Methods: Atherosclerotic plaques in BALB/C mice, maintained on a high-fat diet, were induced with streptozotocin injection and carotid artery ligation and verified by MR imaging. Knottin 3-4A was synthesized by solid-phase peptide synthesis chemistry and coupled to 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) before radiolabeling with 64 Cu. PET probe stability in mouse serum was evaluated. Mice with carotid atherosclerotic plaques were injected via the tail vein with 64 Cu-NOTA-3-4A or 18 F-FDG, followed by small-animal PET/CT imaging at different time points. Receptor targeting specificity of the probe was verified by coinjection of c(RGDyK) administered in molar excess. Subsequently, carotid artery dissection and immunofluorescence staining were performed to evaluate target expression. Results: 64 Cu-NOTA-3-4A was synthesized in high radiochemical purity and yield and demonstrated molecular stability in both phosphate-buffered saline and mouse serum at 4 h. Small-animal PET/CT showed that 64 Cu-NOTA-3-4A accumulated at significantly higher levels in the neovasculature of carotid atherosclerotic plaques (7.41 ± 1.44 vs. 0.67 ± 0.23 percentage injected dose/gram, P < 0.05) than healthy or normal vessels at 1 h after injection. 18 F-FDG also accumulated in atherosclerotic lesions at 0.5 and 1 h after injection but at lower plaque–to–normal tissue ratios than 64 Cu-NOTA-3-4A. For example, plaque–to–normal carotid artery ratios for 18 F-FDG and 64Cu-NOTA-3-4A at 1 h after injection were 3.75 and 14.71 (P < 0.05), respectively. Furthermore, uptake of 64 Cu-NOTA-3-4A in atherosclerotic plaques was effectively blocked (~90% at 1 h after injection) by coinjection of c(RGDyK). Immunostaining confirmed integrin α v β 3 expression in both the infiltrating macrophages and the neovasculature of atherosclerotic plaques. Conclusion: 64 Cu-NOTA-3-4A demonstrates specific accumulation in carotid atherosclerotic plaques in which macrophage infiltration and angiogenesis are responsible for elevated integrin αvβ3 levels. Furthermore, 64 Cu-NOTA-3-4A may demonstrate clinical utility as a PET probe for atherosclerosis imaging or for the evaluation of therapies used to treat atherosclerosis.

62 RADIOLOGY AND NUCLEAR MEDICINE↗